Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of May 21, 2026, XLO trades at $8.44 with a market cap of $48.76M and a P/E ratio of -1.97. XLO moved +1.83% today. Year to date, XLO is -10.87%; over the trailing twelve months it is -32.88%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Xilio Therapeutics, Inc. Common Stock (XLO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. XLO moved +1.83% today.
| Metric | Value |
|---|---|
| Price | $8.44 |
| Market Cap | $48.76M |
| P/E Ratio | -1.97 |
| EPS | $-4.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.80 |
| 52-Week Low | $6.47 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $43.77M |
| Net Income | $-35.04M |
| Gross Margin | 0.00% |
XLO analyst coverage data. Average price target: $0.00.